[144] Revolution Medicines, Inc. SEC Filing

Rhea-AI Filing Summary

Revolution Medicines insider filing details a small, routine proposed sale of company stock. The notice reports that Jeffrey Todd Cislini plans to sell 1,799 common shares through Morgan Stanley Smith Barney on 09/24/2025, with an aggregate market value of $79,524.80 based on the filing. The shares were acquired as restricted stock units on 09/15/2025 and payment or settlement is recorded on that same acquisition date. The filer also disclosed a prior sale of 1,869 shares on 09/16/2025 for gross proceeds of $85,646.74. The filing includes the standard representation that the seller is not aware of undisclosed material information.

Insights

Securities Analyst

TL;DR: Insider sale is immaterial to valuation given the tiny size relative to outstanding shares.

The proposed sale of 1,799 shares represents approximately 0.00096% of the issuer's stated outstanding shares (1,86933,190), indicating this is a routine, non‑material insider liquidity event rather than a signal of company‑level stress. The shares originated from restricted stock units granted on 09/15/2025; the proximity of acquisition and sale dates suggests post‑vesting exercise or plan‑driven disposition. The filing follows Rule 144 notice requirements and names a major broker, Morgan Stanley Smith Barney, which is typical for orderly market execution.

Corporate Governance Expert

TL;DR: Disclosure meets regulatory expectations; no governance red flags in the notice itself.

The Form 144 contains requisite identifiers: acquisition method (RSUs), acquisition and intended sale dates, broker details, and prior recent sale disclosure. The seller's signed representation about lack of material nonpublic information is included, aligning with compliance norms. There is no indication of unusual timing, large percentage disposition, or related‑party transactions in the filing text provided, so governance implications are minimal based on this document alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1799	79524.80	186933190	09/24/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Restricted Stock Units	Issuer			1799	09/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JEFFREY TODD CISLINI 700 Saginaw Drive Redwood City CA 94063	Common	09/16/2025	1869	85646.74

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)